Alemtuzumab induced complete remission of romidepsin-refractory large cell transformation of mycosis fungoides.
Department of Medicine, Queen Mary Hospital, Professorial Block, Hong Kong, China, ylkwong@hkucc.hku.hk.
Yok-Lam
YL
Kwong
D000287:Administration, Topical; D000074323:Alemtuzumab; D061067:Antibodies, Monoclonal, Humanized / Q000008:administration & dosage*; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D047630:Depsipeptides / Q000008:administration & dosage*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009182:Mycosis Fungoides / Q000175:diagnosis / Q000188:drug therapy*; D012074:Remission Induction; D012878:Skin Neoplasms / Q000175:diagnosis / Q000188:drug therapy*
D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D047630:Depsipeptides; D000074323:Alemtuzumab; C087123:romidepsin